| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.003 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.003 |